CSIMarket
 

Ati Physical Therapy Inc   (ATIP)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare

Ati Physical Therapy Inc 's Working Capital Per Sales

ATIP's Working Capital and Revenue growth



ATIP Working Capital Per Revenue (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Working Capital Change -49.14 % -39.64 % -41.55 % -14.87 % 125.01 %
Y / Y Revenue Change 12.69 % 13.18 % 5.54 % 8.52 % -
Working Capital Per Revenue 0.1 0.13 0.15 0.17 0.18
Total Ranking # 437 # 440 # 968 # 580 # 9
Seq. Working Capital Change 12.88 % -12.78 % -39.81 % -14.17 % 33.97 %
Seq. Revenue Change 2.73 % 2.97 % 3.24 % 3.19 % 3.17 %





Comment on ATIP's Working Capital Per Revenue in the fourth quarter 2023
Ati Physical Therapy Inc 's Working Capital Per Revenue in the Q4 2023 sequentially fell to 0.1 below the company average.

Within Healthcare sector 17 other companies have achieved lower Working Capital Per Revenue during the Q4 2023. While Ati Physical Therapy Inc Working Capital Per Revenue overall ranking has impoved so far in the Q4 2023 to 437, from total ranking in the third quarter 2023 at 440.
Working Capital Per Revenue Ranking
Within: No.
Industry # 2
Sector # 18
S&P 500 # 437


Working Capital Per Revenue Statistics
High Average Low
0.3
0.15
0.03
(Sep 30 2022)   (Dec 31 2023)



Financial Statements
Ati Physical Therapy Inc 's Working Capital $ 64 Millions Visit ATIP's Balance sheet
Ati Physical Therapy Inc 's Revenues $ 182 Millions Visit ATIP's Income Statement
Where are ATIP's Sales coming from? Visit ATIP's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Dec 31 2023, within Healthcare Sector Working Capital Per Revenue
Adm Tronics Unlimited Inc   0.29 
Exact Sciences Corporation  0.27 
Encision Inc   0.27 
Viatris Inc   0.26 
Warby Parker Inc   0.26 
Amneal Pharmaceuticals Inc   0.26 
Kewaunee Scientific Corporation  0.26 
Evolus Inc   0.25 
Integer Holdings Corporation  0.25 
Ptc Therapeutics inc   0.25 
Bausch and Lomb Corp  0.25 
Abbott Laboratories  0.25 
Baxter International Inc   0.25 
Docgo Inc   0.25 
Organon and Co   0.25 
Harvard Bioscience Inc  0.24 
Envista Holdings Corporation  0.24 
Integrated Biopharma Inc  0.23 
Steris Plc  0.23 
Aquestive Therapeutics Inc   0.22 
Conmed Corporation  0.22 
Prestige Consumer Healthcare Inc   0.22 
Illumina Inc   0.22 
Healthcare Services Group Inc   0.21 
Ufp Technologies Inc   0.21 
Collegium Pharmaceutical Inc   0.20 
Stryker Corp  0.20 
Theratechnologies Inc   0.20 
Hims and Hers Health Inc   0.20 
Nature s Sunshine Products inc   0.19 
Date modified: 2024-02-28T14:26:19+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com